We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.08B
1-Year Est. Return
25.65%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$1.95B
AUM Growth
+$180M
(+10%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
2.25%
Top 10 Holdings %
Top 10 Hldgs %
24.71%
Holding
1,252
New
88
Increased
327
Reduced
360
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap Value ETF
VOE
|
+$4.63M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.52M |
| 3 |
Truist Financial
TFC
|
+$4.46M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$4.38M |
| 5 |
iShares Gold Trust
IAU
|
+$4.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.79M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$4.4M |
| 3 |
Apple
AAPL
|
+$2.01M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$1.9M |
| 5 |
Vanguard Small-Cap Growth ETF
VBK
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.21% |
| 2 | Healthcare | 10.97% |
| 3 | Industrials | 9.96% |
| 4 | Financials | 9.73% |
| 5 | Consumer Staples | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$465B
| $19.2M | 0.98% |
217,212
+19,769
| +10% | +$1.64M |
|
27
Verizon
VZ
$201B
| $18.6M | 0.95% |
303,224
+9,410
| +3% | +$568K |
|
28
Alphabet (Google) Class A
GOOGL
$4.08T
| $18.5M | 0.95% |
276,020
+6,820
| +3% | +$440K |
|
|
29
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
| $18.2M | 0.93% |
179,235
+43,072
| +32% | +$4.38M |
|
30
AT&T
T
$169B
| $18M | 0.92% |
608,397
+23,365
| +4% | +$675K |
|
31
Walt Disney
DIS
$172B
| $17.1M | 0.87% |
118,178
+23,483
| +25% | +$3.28M |
|
32
SPDR Gold Trust
GLD
$131B
| $16.2M | 0.83% |
113,376
+5,345
| +5% | +$747K |
|
33
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $15.5M | 0.8% |
134,330
-2,448
| -2% | -$272K |
|
34
Visa
V
$697B
| $14.8M | 0.76% |
78,868
-398
| -0.5% | -$71.7K |
|
|
35
Bristol-Myers Squibb
BMY
$130B
| $14.5M | 0.74% |
226,371
+78,958
| +54% | +$4.52M |
|
36
Abbott
ABT
$187B
| $14.3M | 0.73% |
164,117
-1,391
| -0.8% | -$117K |
|
37
Amgen
AMGN
$212B
| $12.8M | 0.65% |
52,955
-499
| -0.9% | -$110K |
|
38
Great Southern Bancorp
GSBC
$879M
| $12.7M | 0.65% |
200,021
-1,050
| -0.5% | -$63.5K |
|
39
NextEra Energy
NEE
$186B
| $12.1M | 0.62% |
200,656
+7,092
| +4% | +$414K |
|
40
Merck
MRK
$326B
| $11.9M | 0.61% |
137,544
+4,763
| +4% | +$391K |
|
41
Mastercard
MA
$497B
| $11.8M | 0.6% |
39,558
+1,458
| +4% | +$411K |
|
42
Meta Platforms (Facebook)
META
$1.51T
| $11.6M | 0.6% |
56,709
+7,913
| +16% | +$1.53M |
|
43
3M
MMM
$94.1B
| $11.4M | 0.58% |
77,406
-6,117
| -7% | -$857K |
|
44
Philip Morris
PM
$312B
| $11.1M | 0.57% |
130,008
-1,622
| -1% | -$134K |
|
|
RTN
45
DELISTED
Raytheon Company
RTN
| $11M | 0.56% |
49,980
+680
| +1% | +$144K |
|
46
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.16B
| $10.5M | 0.54% |
310,569
+21,863
| +8% | +$725K |
|
47
RTX Corp
RTX
$295B
| $10.4M | 0.53% |
110,783
-801
| -0.7% | -$72.7K |
|
48
Coca-Cola
KO
$380B
| $10.3M | 0.53% |
186,158
-2,145
| -1% | -$115K |
|
49
Kimberly-Clark
KMB
$37.5B
| $9.67M | 0.49% |
70,333
-1,862
| -3% | -$252K |
|
50
Thermo Fisher Scientific
TMO
$214B
| $9.59M | 0.49% |
29,515
+255
| +0.9% | +$77.3K |
|
Similar funds
JIM
LFG
VT
LIM
NC
CS
EIC
AC
Central Trust Company's Q4 2019 Portfolio in Review
As of Q4 2019, Central Trust Company held 1,252 positions worth $1.95B, up 10% from $1.77B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Central Trust Company's Q4 2019 filing shows 88 new, 327 increased, 360 reduced and 74 closed positions. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 46,588 shares worth $3.06M. The largest sale was Celgene Corp, an estimated $6.79M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Central Trust Company's largest Q4 2019 buy was State Street SPDR S&P 600 Small Cap Value ETF: 46,588 shares worth $3.06M.
- Central Trust Company added most to Vanguard Mid-Cap Value ETF in Q4 2019, an estimated $4.63M increase.
- Central Trust Company's biggest Q4 2019 reduction was Apple, cutting an estimated $2.01M.
- Central Trust Company fully exited Celgene Corp in Q4 2019, selling an estimated $6.79M.
- Central Trust Company's ten largest holdings make up 25% of its $1.95B portfolio in Q4 2019.
- Central Trust Company opened 88 new positions and closed 74 in Q4 2019.
- Central Trust Company's portfolio value rose 10% quarter-over-quarter to $1.95B.
Based on Central Trust Company's 13F filing for Q4 2019, filed 21 Jan 2020.